Indicative Announcement on Unlocking of the 3rd Sales Restriction Lifting Period under the 2022 Restricted Stock Incentive Plan and Unlocking and Listing of the 2nd Sales Restriction Lifting Period under the 2024 Restricted Stock Incentive Plan

About this update from Gan & Lee Pharmaceuticals Co., Ltd. Class A

Indicative Announcement on Unlocking of the 3rd Sales Restriction Lifting Period under the 2022 Restricted Stock Incentive Plan and Unlocking and Listing of the 2nd Sales Restriction Lifting Period under the 2024 Restricted Stock Incentive Plan The total number of shares to be listed and circulated this time is 3,298,680; the listing and circulation date is June 17, 2026.The abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference:View Attachment

View stock analysis, news, and events for Gan & Lee Pharmaceuticals Co., Ltd. Class A